NewAmsterdam Pharma Correlations
NAMSW Stock | 11.29 0.88 8.45% |
The current 90-days correlation between NewAmsterdam Pharma and NewAmsterdam Pharma is 0.03 (i.e., Significant diversification). The correlation of NewAmsterdam Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
NewAmsterdam Pharma Correlation With Market
Good diversification
The correlation between NewAmsterdam Pharma and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and DJI in the same portfolio, assuming nothing else is changed.
NewAmsterdam |
Moving against NewAmsterdam Stock
0.76 | CVS | CVS Health Corp Earnings Call This Week | PairCorr |
0.71 | JNJ | Johnson Johnson | PairCorr |
0.69 | ENSG | Ensign Group | PairCorr |
0.59 | DERM | Journey Medical Corp Upward Rally | PairCorr |
0.58 | EHC | Encompass Health Corp Earnings Call This Week | PairCorr |
0.58 | PNTG | Pennant Group | PairCorr |
0.55 | AMGN | Amgen Inc Earnings Call This Week | PairCorr |
0.54 | UPC | Universe Pharmaceuticals | PairCorr |
0.53 | INNV | InnovAge Holding Corp Earnings Call This Week | PairCorr |
0.51 | MRK | Merck Company Earnings Call This Week | PairCorr |
0.5 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
0.44 | SNOA | Sonoma Pharmaceuticals Earnings Call This Week | PairCorr |
0.4 | SHPH | Shuttle Pharmaceuticals | PairCorr |
0.4 | NHC | National HealthCare | PairCorr |
0.38 | ABBV | AbbVie Inc Buyout Trend | PairCorr |
0.32 | AKAN | Akanda Corp | PairCorr |
0.5 | VLY | Valley National Bancorp | PairCorr |
0.44 | 301301 | Yili Chuanning Biote | PairCorr |
0.4 | 688739 | Liaoning Chengda Bio | PairCorr |
0.39 | ACW | Actinogen Medical | PairCorr |
0.38 | 688639 | Anhui Huaheng Biotec | PairCorr |
0.38 | 688670 | Jiangsu GDK Biotechnology | PairCorr |
0.38 | BRK-B | Berkshire Hathaway | PairCorr |
0.37 | 300439 | Ningbo MedicalSystem | PairCorr |
0.36 | 300871 | Wuhan Hvsen Biotechnology | PairCorr |
0.31 | ACHC | Acadia Healthcare | PairCorr |
Related Correlations Analysis
-0.04 | -0.55 | -0.02 | 0.36 | NAMS | ||
-0.04 | 0.46 | -0.03 | -0.53 | SCLXW | ||
-0.55 | 0.46 | -0.11 | -0.77 | GRNAW | ||
-0.02 | -0.03 | -0.11 | 0.13 | OABIW | ||
0.36 | -0.53 | -0.77 | 0.13 | ROIVW | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between NewAmsterdam Stock performing well and NewAmsterdam Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NewAmsterdam Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NAMS | 3.11 | 0.41 | 0.07 | (1.59) | 3.71 | 6.54 | 46.55 | |||
SCLXW | 11.50 | 1.22 | 0.06 | 1.24 | 13.27 | 36.00 | 109.99 | |||
GRNAW | 12.98 | (0.30) | (0.01) | 0.00 | 14.82 | 32.45 | 85.19 | |||
OABIW | 8.25 | 0.36 | 0.04 | 0.25 | 9.28 | 21.43 | 58.40 | |||
ROIVW | 4.02 | 0.67 | 0.12 | (2.31) | 4.20 | 8.80 | 24.42 |
NewAmsterdam Pharma Corporate Management
Louise Kooij | Treasurer, CFO | Profile | |
Jim Jacobson | Chief Secretary | Profile | |
Annie Neild | VP Affairs | Profile | |
FESC MD | Chief Founder | Profile | |
Marc MD | Chief Officer | Profile | |
MSc MBA | Chief Officer | Profile | |
Lina Gugucheva | Chief Officer | Profile |